• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS INC. ATELLICA IM INTACT PARATHYROID HORMONE (PTH); RADIOIMMUNOASSAY, PARATHYROID HORMONE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS INC. ATELLICA IM INTACT PARATHYROID HORMONE (PTH); RADIOIMMUNOASSAY, PARATHYROID HORMONE Back to Search Results
Model Number N/A
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/20/2023
Event Type  malfunction  
Event Description
The customer reported an observation of discordant elevated intact parathyroid hormone (pth) results on multiple patient(s) samples on atellica im 1600 analyzer.The initial results were reported to the physician(s), who did not question the results.All the samples were repeated on alternate atellica im 1600 analyzers and the results were lower compared to the initial results.These results were considered as correct results by the physician(s).A corrected report was issued.There are no known reports of patient intervention or adverse health consequences due to this issue.
 
Manufacturer Narrative
A customer from outside the united states reported an observation of discordant elevated intact parathyroid hormone (pth) results on multiple patient(s) samples on atellica im 1600 analyzer.The initial results were reported to the physician(s), who did not question the results.All the samples were repeated on alternate atellica im 1600 analyzers and the results were lower compared to the initial results.These results were considered as correct results by the physician(s).A corrected report was issued.Siemens reviewed the calibration and identified that quality control results were outside established ranges.Customer proceeded to report the patient samples despite qc failure.The interpretation of results section of the atellica im intact parathyroid hormone (pth) instructions for use (ifu) states: "results of this assay should always be interpreted in conjunction with the patient's medical history, clinical presentation, and other findings." siemens healthcare diagnostics is evaluating.A separate mdr was filed for a different date of testing for the same issue.
 
Manufacturer Narrative
Siemens filed the initial mdr 1219913-2024-00006 on 17-jan-2024.Additional information on 24-jan-2024: a customer from outside the united states reported an observation of discordant elevated intact parathyroid hormone (pth) results on multiple patient(s) samples on atellica im 1600 analyzer.The initial results were reported to the physician(s), who did not question the results.On (b)(6) 2023, the customer loaded and calibrated atellica im pth reagent lot 096 on atellica im sn# (b)(6).The calibration was valid although the recovery was low and quality control (qc) with this calibration recovered high and out of insert ranges.Several patient samples were processed with this calibration and needed to be corrected.The calibration, qc and discordant samples used the same reagent pack.These samples were repeated on alternate atellica im analyzers, which produced lower results compared to the initial results.The lower values obtained were deemed correct by the customer.Atellica im sn# (b)(6) was recalibrated with another reagent pack of pth lot 096 and the calibration and controls were acceptable.Based on the available information, the cause of the elevated qc and patient results is consistent with an isolated reagent handling issue.The customer is operational and continues to use pth reagent lot 096 without further concern.In section h6, the investigation finding, and investigation conclusion codes were updated.Mdr 1219913-2024-00005 supplemental 1 was filed for a different date of testing for the same updates.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATELLICA IM INTACT PARATHYROID HORMONE (PTH)
Type of Device
RADIOIMMUNOASSAY, PARATHYROID HORMONE
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
511 benedict avenue
tarrytown NY 10591
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
333 coney street
east walpole MA 02032
Manufacturer Contact
stacy loukos
333 coney street
east walpole
east walpole, MA 02032
3392064073
MDR Report Key18530121
MDR Text Key333348574
Report Number1219913-2024-00006
Device Sequence Number1
Product Code CEW
UDI-Device Identifier00630414599458
UDI-Public00630414599458
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
K163658
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 02/13/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/17/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue Number10995622
Device Lot Number096
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/24/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/10/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-